Search

Your search keyword '"Lovisa, Federica"' showing total 4 results
Start Over Author "Lovisa, Federica" Publisher ferrata storti foundation
4 results on '"Lovisa, Federica"'

1. TP53 DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.

Author

Martire G, Lovisa F, Carraro E, Rizzato D, Cesaro S, Mura RM, Tondo A, Bertolin C, Boaretto F, Salviati L, Biffi A, Pillon M, and Mussolin L

Subjects
Humans, Child, Prognosis, Male, Female, Child, Preschool, Adolescent, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Rituximab therapeutic use, Burkitt Lymphoma genetics, Burkitt Lymphoma drug therapy, Burkitt Lymphoma mortality, Burkitt Lymphoma diagnosis, Mutation, Tumor Suppressor Protein p53 genetics
Published
2024
Full Text
View/download PDF

2. miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma.

Author

Garbin A, Lovisa F, Holmes AB, Damanti CC, Gallingani I, Carraro E, Accordi B, Veltri G, Pizzi M, d'Amore ESG, Pillon M, Biffi A, Basso K, and Mussolin L

Subjects
Anaplastic Lymphoma Kinase, Cell Line, Tumor, Child, Gene Expression Regulation, Neoplastic, Humans, Receptor Protein-Tyrosine Kinases genetics, Transcription Factors genetics, Lymphoma, Large-Cell, Anaplastic genetics, MicroRNAs genetics
Published
2021
Full Text
View/download PDF

3. A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma.

Author

Lovisa F, Binatti A, Coppe A, Primerano S, Carraro E, Pillon M, Pizzi M, Guzzardo V, Buffardi S, Porta F, Farruggia P, De Santis R, Bulian P, Basso G, Lazzari E, d'Amore ESG, Bortoluzzi S, and Mussolin L

Subjects
Adolescent, Child, Child, Preschool, Computational Biology, DNA Mutational Analysis, Exons, Extracellular Signal-Regulated MAP Kinases metabolism, Female, Humans, Immunohistochemistry, Interferon Regulatory Factors genetics, MAP Kinase Kinase 1 genetics, MAP Kinase Signaling System, Male, Receptors, Tumor Necrosis Factor, Member 14 genetics, Sequence Analysis, DNA, Genetic Variation, Lymphoma, Follicular genetics, Lymphoma, Follicular metabolism, Mutation, Exome Sequencing
Published
2019
Full Text
View/download PDF

4. Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.

Author

De Smedt R, Peirs S, Morscio J, Matthijssens F, Roels J, Reunes L, Lintermans B, Goossens S, Lammens T, Van Roy N, Touzart A, Jenni S, Tsai YC, Lovisa F, Mussolin L, Serafin V, Van Nieuwerburgh F, Deforce D, Uyttebroeck A, Tousseyn T, Burkhardt B, Klapper W, De Moerloose B, Benoit Y, Macintyre E, Bourquin JP, Basso G, Accordi B, Bornhauser B, Meijerink J, Vandenberghe P, and Van Vlierberghe P

Subjects
Cell Line, Tumor, Drug Screening Assays, Antitumor, Humans, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma enzymology, Protein Kinase Inhibitors pharmacology, Proto-Oncogene Proteins c-pim-1 antagonists & inhibitors, Proto-Oncogene Proteins c-pim-1 metabolism
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results